Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 248919-64-4
2. Azd0865
3. Azd-0865
4. E0ou4sc8dp
5. 847574-05-4
6. Chembl497011
7. 8-[(2,6-dimethylphenyl)methylamino]-n-(2-hydroxyethyl)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamide
8. 8-(((2,6-dimethylphenyl)methyl)amino)-n-(2-hydroxyethyl)-2,3-dimethylimidazo(1,2-a)pyridine-6-carboxamide
9. 8-((2,6-dimethylbenzyl)amino)-n-(2-hydroxyethyl)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamide
10. Linaprazan [inn]
11. Linaprazan [inn:ban]
12. Unii-e0ou4sc8dp
13. 8-[(2,6-dimethylbenzyl)amino]-n-(2-hydroxyethyl)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamide
14. 8-{[(2,6-dimethylphenyl)methyl]amino}-n-(2-hydroxyethyl)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamide
15. Azd0865(linaprazan)
16. Schembl1138353
17. Dtxsid90870279
18. Azd 0865
19. Yja91964
20. Zinc1547156
21. Bdbm50268741
22. Cs-5725
23. 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-n-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide
24. Hy-100412
25. A911885
26. Q27276714
27. 2,3-dimethyl-8-[(2,6-dimethylbenzyl)amino]-6-[n-(2-hydroxyethyl)aminocarbonyl]imidazo[1,2-a]pyridine
28. 8-(2,6-dimethylbenzylamino)-n-(2-hydroxyethyl)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamide
| Molecular Weight | 366.5 g/mol |
|---|---|
| Molecular Formula | C21H26N4O2 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | 366.20557608 g/mol |
| Monoisotopic Mass | 366.20557608 g/mol |
| Topological Polar Surface Area | 78.7 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 493 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
18
PharmaCompass offers a list of Linaprazan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Linaprazan manufacturer or Linaprazan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Linaprazan manufacturer or Linaprazan supplier.
PharmaCompass also assists you with knowing the Linaprazan API Price utilized in the formulation of products. Linaprazan API Price is not always fixed or binding as the Linaprazan Price is obtained through a variety of data sources. The Linaprazan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Linaprazan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Linaprazan, including repackagers and relabelers. The FDA regulates Linaprazan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Linaprazan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Linaprazan supplier is an individual or a company that provides Linaprazan active pharmaceutical ingredient (API) or Linaprazan finished formulations upon request. The Linaprazan suppliers may include Linaprazan API manufacturers, exporters, distributors and traders.
Linaprazan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Linaprazan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Linaprazan GMP manufacturer or Linaprazan GMP API supplier for your needs.
A Linaprazan CoA (Certificate of Analysis) is a formal document that attests to Linaprazan's compliance with Linaprazan specifications and serves as a tool for batch-level quality control.
Linaprazan CoA mostly includes findings from lab analyses of a specific batch. For each Linaprazan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Linaprazan may be tested according to a variety of international standards, such as European Pharmacopoeia (Linaprazan EP), Linaprazan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Linaprazan USP).
